A twice-yearly injection may soon change how high blood pressure is treated. In a global trial, patients receiving the experimental drug zilebesiran alongside standard therapy saw greater blood pressure reductions than those on standard treatment alone. The drug works by blocking a key liver protein, helping blood vessels relax. Researchers say this long-lasting approach could make it much easier for patients to keep their condition under control.
source https://www.sciencedaily.com/releases/2026/04/260411022035.htm
Gnutella: a protocol outliving the world that created it
-
Now that’s a name I haven’t heard in a long time.
Gnutella is a file sharing protocol that many have forgotten and it has the
story of a decentralized te...
20 hours ago
No comments:
Post a Comment